M

Medivate Partners

7 employees

Medivate Partners LLC is an investment arm of Posco specializing in cross border, growth capital, early stage and mid stage.

Investor insights

Sectors invested in

Biotechnology6
Health Care3
Therapeutics2
Pharmaceutical1
Medical Device1
Japanese Bridging1
Medical Monitoring1
Nicotine1
CRO Services1
Vaccine Development1
Regulatory Affairs1
Global Clinical Development1
Clinical Monitoring1
Phase I1
Ethnobridging1
ENDS1
Ophthlamology1
Phase II1
Phase 1 Clinical Trials1
Adaptive Clinical Trials1

Funding rounds participated in

$28M sweet spot round size

Most of their 9 investments are in rounds between $16K and $33M

Investor type

Venture Capital

Basic info

Industry

venture capital and private equity principals

Sectors

Biotech/Healthcare Investment
Private Equity Fund
Growth Capital
Venture Capital

Date founded

2012

Investments made

C

Cipherome, Inc raised $16K on February 14, 2022

Investors: InterVest, Nautilus Venture Partners and Medivate Partners

U

Undisclosed raised $28M on September 10, 2020

Investors: NH Investment & Securities and Medivate Partners

A

Artiva Biotherapeutics raised $78M on June 26, 2020

Investors: RA Capital Management, L.P., venBio Partners, 5AM Ventures and Medivate Partners

U

Undisclosed raised undisclosed on January 22, 2020

Investors: Medivate Partners

W

WindMIL Therapeutics raised $33M on June 18, 2018

Investors: FoxKiser, Qiming Venture Partners, Domain Associates, Camden Partners and Medivate Partners

U

Undisclosed raised undisclosed on February 20, 2018

Investors: Tennenbaum Capital Partners, LLC and Medivate Partners

W

Wacker Biotech US raised undisclosed on January 1, 2018

Investors: Medivate Partners

S

SillaJen raised $12M on March 21, 2016

Investors: Medivate Partners

W

WCCT Global raised undisclosed on January 1, 2015

Investors: Medivate Partners

FAQ